This activity was planned with a goal to enable participants to learn best practices when prescribing bempedoic acid to the statin intolerant patient. This activity is part of the Bempedoic Acid: New Evidence Transforming the LDL-C Treatment Landscape grant supported by Esperion.
Important Dates: Date of Release: July 23, 2025Term of Approval/Date of Expiration: August 31, 2026 Learner Objective: Upon completion of this activity, you should be able to:
Identify statin-intolerant patients who may benefit from bempedoic acid and integrate this therapy into clinical practice.
Acknowledgement Educational grant support provided by: Esperion.
Faculty:Erin D. Michos, MD, FACC